NCT04734587View on ClinicalTrials.gov

Evaluation of Brain Damage Due to Coronary Angioplasty in Percutaneous Intervention Patients

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 18, 2019

Primary Completion Date

March 25, 2020

Study Completion Date

March 25, 2020

Conditions
Silent StrokeCoronary Disease
Interventions
DIAGNOSTIC_TEST

Blood serum Neuron-specific Enolase measurement

The Silent Brain Injury ratio was compared by measuring the Neuron-specific enzyme level with venous blood sampling from both patient groups before and after percutaneous coronary intervention.

Trial Locations (1)

Unknown

Ondokuzmayis University, Samsun

All Listed Sponsors
lead

Ondokuz Mayıs University

OTHER

NCT04734587 - Evaluation of Brain Damage Due to Coronary Angioplasty in Percutaneous Intervention Patients | Biotech Hunter | Biotech Hunter